NOBAMEDI is a leading enterprise specializing in the manufacturing and export of aesthetic devices, including Solution Delivery Systems, Multi-Pin Needles, Syringe Mixing Tubes, and Needle Stoppers. The company is dedicated to the research and development, design, manufacturing, and sales of aesthetic appliances. Headquartered in Gyeonggi, South Korea, it operates a manufacturing plant equipped with a clean room environment. Its products are sold in global markets such as Europe, North America, Latin America, the Middle East, and Southeast Asia, showing consistent annual revenue growth.NOBAMEDIisaleadingenterprisespecializinginthemanufacturingandexportofaestheticdevices,includingSolutionDeliverySystems,Multi-PinNeedles,SyringeMixingTubes,andNeedleStoppers.Thecompanyisdedicatedtotheresearchanddevelopment,design,manufacturing,andsalesofaestheticappliances.HeadquarteredinGyeonggi,SouthKorea,itoperatesamanufacturingplantequippedwithacleanroomenvironment.ItsproductsaresoldinglobalmarketssuchasEurope,NorthAmerica,LatinAmerica,theMiddleEast,andSoutheastAsia,showingconsistentannualrevenuegrowth.
Key Products/TechnologiesKeyProducts/Technologies
Key product categories include Solution Delivery Systems, Multi-Pin Needles, Syringe Mixing Tubes, and Needle Stoppers. Specific product lines feature Crystal Fill Hydro, Hycoox Multi Suction Injector, Crystal MESO, Crystal Care Multi Needle Series (3-pin, 5-pin, 9-pin, and 9-pin adjustable multi-needles), Crystal Care Scalp, Crystal Care Skin, and Cosmetic Injectors.KeyproductcategoriesincludeSolutionDeliverySystems,Multi-PinNeedles,SyringeMixingTubes,andNeedleStoppers.SpecificproductlinesfeatureCrystalFillHydro,HycooxMultiSuctionInjector,CrystalMESO,CrystalCareMultiNeedleSeries(3-pin,5-pin,9-pin,and9-pinadjustablemulti-needles),CrystalCareScalp,CrystalCareSkin,andCosmeticInjectors.
Proprietary technologies include ETW (Extra Thin Wall) and triple-cutting bevel shape needle technology to reduce injection pain. Advanced solution leakage prevention technology, featuring a delicate structure that minimizes solution loss and increases negative pressure between the skin and needle. Auto-sensing suction control technology for precise solution injection and significant reduction in loss. The company is also recognized as the first in Korea to produce 34-gauge multi-needles.ProprietarytechnologiesincludeETW(ExtraThinWall)andtriple-cuttingbevelshapeneedletechnologytoreduceinjectionpain.Advancedsolutionleakagepreventiontechnology,featuringadelicatestructurethatminimizessolutionlossandincreasesnegativepressurebetweentheskinandneedle.Auto-sensingsuctioncontroltechnologyforprecisesolutioninjectionandsignificantreductioninloss.ThecompanyisalsorecognizedasthefirstinKoreatoproduce34-gaugemulti-needles.
Core AdvantagesCoreAdvantages
A specialized enterprise in aesthetic medical devices and consumables, holding a leading position in the market through innovative technology.Aspecializedenterpriseinaestheticmedicaldevicesandconsumables,holdingaleadingpositioninthemarketthroughinnovativetechnology.
Proprietary needle technology (ETW, triple-cutting, coating) serves as a key differentiator, reducing patient discomfort and enhancing treatment efficacy.Proprietaryneedletechnology(ETW,triple-cutting,coating)servesasakeydifferentiator,reducingpatientdiscomfortandenhancingtreatmentefficacy.
Development capabilities for advanced solution delivery systems that ensure minimal leakage and precise injection control.Developmentcapabilitiesforadvancedsolutiondeliverysystemsthatensureminimalleakageandpreciseinjectioncontrol.
Integrated capabilities encompassing research and development, design, manufacturing, and sales, allowing for comprehensive product lifecycle management.Integratedcapabilitiesencompassingresearchanddevelopment,design,manufacturing,andsales,allowingforcomprehensiveproductlifecyclemanagement.
Operation of a manufacturing plant with a clean room environment, guaranteeing high product quality and safety standards.Operationofamanufacturingplantwithacleanroomenvironment,guaranteeinghighproductqualityandsafetystandards.
Extensive global market penetration across Europe, North America, Latin America, the Middle East, and Southeast Asia, ensuring stable revenue growth.ExtensiveglobalmarketpenetrationacrossEurope,NorthAmerica,LatinAmerica,theMiddleEast,andSoutheastAsia,ensuringstablerevenuegrowth.
Acquisition of numerous international and domestic certifications, including GMP, ISO, CE, and KFDA, affirming product reliability and global competitiveness.Acquisitionofnumerousinternationalanddomesticcertifications,includingGMP,ISO,CE,andKFDA,affirmingproductreliabilityandglobalcompetitiveness.
Possession of 9 patents, 21 design patents, and 8 registered trademarks, highlighting technological originality and intellectual property protection.Possessionof9patents,21designpatents,and8registeredtrademarks,highlightingtechnologicaloriginalityandintellectualpropertyprotection.
Target IndustrieTargetIndustrie
Primary application of products and technologies within the aesthetic and cosmetic industry.Primaryapplicationofproductsandtechnologieswithintheaestheticandcosmeticindustry.
Contribution to the market through the provision of advanced skin and scalp care solutions.Contributiontothemarketthroughtheprovisionofadvancedskinandscalpcaresolutions.
Involvement in the manufacturing and distribution of medical devices for minimally invasive surgery.Involvementinthemanufacturinganddistributionofmedicaldevicesforminimallyinvasivesurgery.
**Certifications**: GMP, ISO13485, ISO22716, MDD CE (CE2195 for Crystal Meso, Multi-needle, Hycoox), KFDA (Crystal Injector, multi needles, Crystal Care solution, Hycoox, Crystal Meso), Brazil INMETRO/ANVISA (Crystal Meso, Hycoox), China CFDA (Crystal Multi-needle), Taiwan TFDA (Multi-needle, Hycoox), Product-Specific Approved Exporter by Korean customs, Gyeonggi Promising Enterprise.**Certifications**:GMP,ISO13485,ISO22716,MDDCE(CE2195forCrystalMeso,Multi-needle,Hycoox),KFDA(CrystalInjector,multineedles,CrystalCaresolution,Hycoox,CrystalMeso),BrazilINMETRO/ANVISA(CrystalMeso,Hycoox),ChinaCFDA(CrystalMulti-needle),TaiwanTFDA(Multi-needle,Hycoox),Product-SpecificApprovedExporterbyKoreancustoms,GyeonggiPromisingEnterprise.
**Patents**: Holds a total of 9 patents, 21 design patents, and 8 registered trademarks.**Patents**:Holdsatotalof9patents,21designpatents,and8registeredtrademarks.
Key patents include an exclusive needle patent (ETW, triple-cutting, coating technology for reduced pain), a skin treatment module patent (for minimal leakage and increased negative pressure), design patents for the Crystal Care Series, and an auto-sensing patent (for suction control technology).Keypatentsincludeanexclusiveneedlepatent(ETW,triple-cutting,coatingtechnologyforreducedpain),askintreatmentmodulepatent(forminimalleakageandincreasednegativepressure),designpatentsfortheCrystalCareSeries,andanauto-sensingpatent(forsuctioncontroltechnology).
Introduction
Location
58 Daeji-ro, Suji-gu, Yongin-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
Information
58 Daeji-ro, Suji-gu, Yongin-si, Gyeonggi-do, South Korea